Literature DB >> 28646476

The relationship between circulating adiponectin, leptin and vaspin with bone mineral density (BMD), arterial calcification and stiffness: a cross-sectional study in post-menopausal women.

N Tanna1, K Patel1, A E Moore2, D Dulnoan2, S Edwards2, G Hampson3,4.   

Abstract

OBJECTIVE: To explore the relationship between circulating adiponectin, leptin and vaspin with bone mineral density (BMD), arterial stiffness and vascular calcification in post-menopausal women. We hypothesised that adipokines produced by adipose tissue may be mediators of bone and cardiovascular disease (CVD) and explain, in part, the observed association between osteoporosis and CVD.
DESIGN: We studied 386 ambulant community dwelling postmenopausal women aged (mean [SD] 61 [6.4] years). BMD at the lumbar spine, femoral neck (FN), and total hip (TH), body composition; fat mass (FM) and lean mass (LM) as well as abdominal aortic calcification (AAC) were determined by dual energy X-ray absorptiometry. Pulse wave velocity (PWV) and augmentation index, markers of arterial stiffness were measured. Fasting adiponectin, leptin and vaspin were quantified in serum.
RESULTS: A positive independent association was observed between vaspin and BMD at the FN (p = 0.009), TH (p = 0.037) in the whole study population adjusted for confounders including age, FM, LM and lifestyle variables. Using the same model, a negative association was seen between adiponectin and BMD at the FN in women with osteoporosis (p = 0.043). Serum adiponectin was significantly higher in women with fractures (20.8 [9.3] µg/ml compared to those without (18.5 [8.6] µg/ml, p = 0.018) and associated with a significant increased risk of fracture (HR 1.032, 95% CI 1.003-1.063, p = 0.032). Leptin was not associated with BMD or fracture risk after adjustment. Adiponectin was independently associated with AAC (p = 0.007) and significantly higher in women with AAC scores > 1; (19.2[9.2]) compared to those with no or low AAC scores (<1); 16.8 [8.0], p = 0.018). In adjusted analyses, PWV velocity was positively associated with circulating vaspin (p = 0.039) and AI was negatively associated with serum leptin (p = 0.002).
CONCLUSION: Adiponectin, leptin, vaspin are related to markers of bone and vascular health and may contribute to the observed association between osteoporosis and CVD.

Entities:  

Keywords:  Adiponectin; Bone density; Leptin; Vascular calcification; Vaspin

Mesh:

Substances:

Year:  2017        PMID: 28646476     DOI: 10.1007/s40618-017-0711-1

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  49 in total

Review 1.  Relationships between fat and bone.

Authors:  I R Reid
Journal:  Osteoporos Int       Date:  2007-10-27       Impact factor: 4.507

2.  Leptin causes nitric-oxide independent coronary artery vasodilation in humans.

Authors:  Keiji Matsuda; Hiroki Teragawa; Yukihiro Fukuda; Keigo Nakagawa; Yukihito Higashi; Kazuaki Chayama
Journal:  Hypertens Res       Date:  2003-02       Impact factor: 3.872

3.  Adiponectin increases bone mass by suppressing osteoclast and activating osteoblast.

Authors:  Kazuya Oshima; Akihide Nampei; Morihiro Matsuda; Masanori Iwaki; Atsunori Fukuhara; Jun Hashimoto; Hideki Yoshikawa; Iichiro Shimomura
Journal:  Biochem Biophys Res Commun       Date:  2005-06-03       Impact factor: 3.575

4.  Plasma vaspin concentrations are elevated in metabolic syndrome in men and are correlated with coronary atherosclerosis in women.

Authors:  Sung Hee Choi; Soo Heon Kwak; Yenna Lee; Min Kyung Moon; Soo Lim; Young Joo Park; Hak C Jang; Min Seon Kim
Journal:  Clin Endocrinol (Oxf)       Date:  2011-11       Impact factor: 3.478

Review 5.  Sclerostin and DKK1: new players in renal bone and vascular disease.

Authors:  Pieter Evenepoel; Patrick D'Haese; Vincent Brandenburg
Journal:  Kidney Int       Date:  2015-06-17       Impact factor: 10.612

6.  Sex differences in the association between adiponectin and BMD, bone loss, and fractures: the Rancho Bernardo study.

Authors:  Maria Rosario G Araneta; Denise von Mühlen; Elizabeth Barrett-Connor
Journal:  J Bone Miner Res       Date:  2009-12       Impact factor: 6.741

7.  Obesity and fractures in postmenopausal women.

Authors:  Melissa Orlandin Premaor; Lesley Pilbrow; Carol Tonkin; Richard A Parker; Juliet Compston
Journal:  J Bone Miner Res       Date:  2010-02       Impact factor: 6.741

8.  Relationship of vaspin and apelin levels with insulin resistance and atherosclerosis in metabolic syndrome.

Authors:  B Karbek; N C Bozkurt; O Topaloglu; M S Aslan; A Gungunes; E Cakal; T Delibasi
Journal:  Minerva Endocrinol       Date:  2014-06       Impact factor: 2.184

Review 9.  Bone loss and vascular calcification: A bi-directional interplay?

Authors:  Cristina Vassalle; Annamaria Mazzone
Journal:  Vascul Pharmacol       Date:  2016-07-04       Impact factor: 5.773

10.  Bone Mineral Density and Body Composition are Associated with Circulating Angiogenic Factors in Post-menopausal Women.

Authors:  A Spangenberg; N Maghsoodi; D Dulnoan; A E Moore; S Edwards; M L Frost; G Hampson
Journal:  Calcif Tissue Int       Date:  2016-08-30       Impact factor: 4.333

View more
  13 in total

1.  MOTS-c peptide regulates adipose homeostasis to prevent ovariectomy-induced metabolic dysfunction.

Authors:  Huanyu Lu; Ming Wei; Yue Zhai; Qingyang Li; Zichen Ye; Li Wang; Wenjing Luo; Jingyuan Chen; Zifan Lu
Journal:  J Mol Med (Berl)       Date:  2019-02-06       Impact factor: 4.599

2.  Diabetes and Abdominal Aortic Calcification-a Systematic Review.

Authors:  Emilie Frey Bendix; Eskild Johansen; Thomas Ringgaard; Martin Wolder; Jakob Starup-Linde
Journal:  Curr Osteoporos Rep       Date:  2018-02       Impact factor: 5.096

3.  Examining the causal role of leptin in bone mineral density: A Mendelian randomization study.

Authors:  Xiang-He Meng; Li-Jun Tan; Hong-Mei Xiao; Bei-Sha Tang; Hong-Wen Deng
Journal:  Bone       Date:  2019-05-08       Impact factor: 4.398

4.  Compliant substratum modulates vinculin expression in focal adhesion plaques in skeletal cells.

Authors:  Chenchen Zhou; Qingxuan Wang; Demao Zhang; Linyi Cai; Wei Du; Jing Xie
Journal:  Int J Oral Sci       Date:  2019-06-01       Impact factor: 6.344

5.  Links between arterial stiffness and bone mineral density in middle-aged and elderly Chinese individuals: a cross-sectional study.

Authors:  Meng Zhang; Lijuan Bai; Jing Kang; Jing Ge; Wen Peng
Journal:  BMJ Open       Date:  2019-08-10       Impact factor: 2.692

6.  Positive Association of Leptin and Artery Calcification of Lower Extremity in Patients With Type 2 Diabetes Mellitus: A Pilot Study.

Authors:  SanBao Chai; Yao Chen; SiXu Xin; Ning Yuan; YuFang Liu; JianBin Sun; XiangYu Meng; YongFen Qi
Journal:  Front Endocrinol (Lausanne)       Date:  2021-05-19       Impact factor: 5.555

7.  Anti-Atherogenic Effects of Vaspin on Human Aortic Smooth Muscle Cell/Macrophage Responses and Hyperlipidemic Mouse Plaque Phenotype.

Authors:  Kengo Sato; Remina Shirai; Maho Yamaguchi; Tomoyuki Yamashita; Koichiro Shibata; Taisuke Okano; Yusaku Mori; Taka-Aki Matsuyama; Hatsue Ishibashi-Ueda; Tsutomu Hirano; Takuya Watanabe
Journal:  Int J Mol Sci       Date:  2018-06-11       Impact factor: 5.923

8.  Association between Bone Mineral Density and Albuminuria: Cross-Sectional Analysis of Data from the 2011 Korea National Health and Nutrition Examination Survey V-2.

Authors:  Tae Yang Yu; Ha Young Kim; Jeong Mi Lee; Dae Ho Lee; Chung Gu Cho
Journal:  Endocrinol Metab (Seoul)       Date:  2018-05-04

9.  Influence of bone mineral density in circulating adipokines among postmenopausal Arab women.

Authors:  Mohammed Ghouse Ahmed Ansari; Syed Danish Hussain; Kaiser Ahmed Wani; Sobhy M Yakout; Dara Al-Disi; Majed S Alokail; Jean-Yves Reginster; Nasser M Al-Daghri
Journal:  Saudi J Biol Sci       Date:  2019-10-31       Impact factor: 4.219

Review 10.  Uremic Toxins and Vascular Calcification-Missing the Forest for All the Trees.

Authors:  Nikolas Rapp; Pieter Evenepoel; Peter Stenvinkel; Leon Schurgers
Journal:  Toxins (Basel)       Date:  2020-09-29       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.